Biofrontera Inc (BFRI) is a Healthcare · Drug Manufacturers - Specialty & Generic company listed on NASDAQ. Price $1.32 (+6.45%), Market cap $0.01B, 52-week low–high $0.56 ~ $1.16.
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.
Financial statements, price targets, institutional (13F) holdings and related news for Biofrontera Inc are updated in real time on BlackAll Trade.
Biofrontera Inc trades at $1.32 (+6.45%). Real-time quotes and charts are available on BlackAll Trade.
Biofrontera Inc has a market cap of about $0.01B.
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-Rho